Molineaux S M, Casano F J, Rolando A M, Peterson E P, Limjuco G, Chin J, Griffin P R, Calaycay J R, Ding G J, Yamin T T
Department of Molecular Immunology, Merck Research Laboratories, Rahway, NJ 07065.
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1809-13. doi: 10.1073/pnas.90.5.1809.
Murine interleukin 1 beta (IL-1 beta) convertase (mICE) was identified in cytosolic extracts of peritoneal exudate cells (PECs) and macrophage cell lines. mICE cleaves both the human and mouse IL-1 beta precursors (pIL-1 beta) at sites 1 and 2 but fails to cleave a human pIL-1 beta (Asp116 to Ala) mutant at site 2, indicating that Asp is required to the left of the scissile bond. Ac-Tyr-Val-Ala-Asp-amino-4-methyl coumarin, patterned after site 2 of human pIL-1 beta, is a fluorogenic substrate for mICE, while the tetrapeptide aldehyde Ac-Tyr-Val-Ala-Asp-CHO is a potent inhibitor (Ki = 3 nM) that prevents generation and release of mature IL-1 beta by PECs (IC50 = 7 microM). Cloning of a full-length 1.4-kb cDNA shows that mICE is encoded as a 402-aa proenzyme (p45) that can be divided into a prodomain (Met1-Asp122), followed by a p20 subunit (Gly123-Asp296), a connecting peptide (Ser297-Asp314), and a p10 subunit (Gly315-His402). At the amino acid level, p45, p20, and p10 are 62%, 60%, and 81% identical with human IL-1 beta convertase (hICE). The active site Cys284 lies within a completely conserved stretch of 18 residues; however, Ser289 in hICE, which aligns with the catalytic region of serine and viral cysteinyl proteases, is absent from mICE. Expression in Escherichia coli of a truncated cDNA encoding Asn119-His402 generated active enzyme, which was autocatalytically processed at three internal Asp-Xaa bonds to generate a p20 subunit (Asn119-Asp296) complexed with either p11 (Ala309-His402) or p10. Recombinant mICE cleaves murine pIL-1 beta accurately at the Asp117-Val118 bond. The striking similarities of the human and murine enzymes will make it possible to assess the therapeutic potential of hICE inhibitors in murine models of disease.
在腹膜渗出细胞(PEC)和巨噬细胞系的胞质提取物中鉴定出小鼠白细胞介素1β(IL-1β)转化酶(mICE)。mICE可在1号和2号位点切割人及小鼠的IL-1β前体(pIL-1β),但无法在2号位点切割人pIL-1β(Asp116突变为Ala)突变体,这表明在切割键左侧需要Asp。以人pIL-1β的2号位点为模板的Ac-Tyr-Val-Ala-Asp-氨基-4-甲基香豆素是mICE的荧光底物,而四肽醛Ac-Tyr-Val-Ala-Asp-CHO是一种强效抑制剂(Ki = 3 nM),可阻止PEC产生和释放成熟的IL-1β(IC50 = 7 microM)。全长1.4 kb cDNA的克隆表明,mICE编码为一种402个氨基酸的酶原(p45),可分为一个前结构域(Met1-Asp122),接着是一个p20亚基(Gly123-Asp296)、一个连接肽(Ser297-Asp314)和一个p10亚基(Gly315-His402)。在氨基酸水平上,p45、p20和p10与人IL-1β转化酶(hICE)的同源性分别为62%、60%和81%。活性位点Cys284位于一段完全保守的18个残基区域内;然而,hICE中与丝氨酸和病毒半胱氨酸蛋白酶催化区域对齐的Ser289在mICE中不存在。编码Asn119-His402的截短cDNA在大肠杆菌中表达产生了活性酶,该酶在三个内部Asp-Xaa键处进行自催化加工,生成与p11(Ala309-His402)或p10复合的p20亚基(Asn119-Asp296)。重组mICE可在Asp-117-Val118键处精确切割小鼠pIL-1β。人和小鼠酶的显著相似性将使得在小鼠疾病模型中评估hICE抑制剂的治疗潜力成为可能。